Aurobindo Pharma Limited Aurobindo Pharma Limited

Aurobindo Pharma Limited

AUROPHARMA

Peringkat dalam Saham #2072
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Harga Saham
$17.34
Kapitalisasi Pasar
$9.98B
Perubahan (1 hari)
-3.08%
Perubahan (1 tahun)
38.71%
Negara
IN
Perdagangan Aurobindo Pharma Limited (AUROPHARMA)

Kategori

Healthcare
Rasio P/S untuk Aurobindo Pharma Limited (AUROPHARMA)
Rasio P/S per October 2026 TTM: 2.77
Menurut laporan keuangan dan harga saham terbaru dari Aurobindo Pharma Limited, rasio P/S saat ini (TTM) adalah 2.77. Pada akhir 2024, rasio P/S perusahaan adalah 2.25.
Riwayat rasio P/S untuk Aurobindo Pharma Limited dari 2004 hingga 2026
Rasio P/S pada akhir setiap tahun
Tahun Rasio P/S Mengubah
2026 (TTM) 2.77 33.31%
2025 2.08 -7.36%
2024 2.25 82.40%
2023 1.23 -26.44%
2022 1.68 -20.27%
2021 2.10 97.49%
2020 1.06 -55.13%
2019 2.37 10.73%
2018 2.14 -20.47%
2017 2.69 -15.48%
2016 3.19 7.66%
2015 2.96 59.79%
2014 1.85 142.25%
2013 0.77 0.21%
2012 0.76 -40.71%
2011 1.29 -11.40%
2010 1.45 342.21%
2009 0.33 -48.77%
2008 0.64 -62.35%
2007 1.70 -24.28%
2006 2.25 103.16%
2005 1.11 -7.07%
2004 1.19 0.00%
Rasio P/S untuk perusahaan sejenis atau pesaing